Skip to content

Comparison of Human Embryo Development Using Sequential and Single Media With Time-lapse Imaging

Comparison of Human Embryonic Development Using Sequential and Single Media in IVF Monitored by Time-lapse Imaging.

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01939626
Enrollment
128
Registered
2013-09-11
Start date
2013-09-30
Completion date
2014-02-28
Last updated
2021-01-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Infertility

Keywords

embryo, culture

Brief summary

The purpose of this study is to compare human embryo in vitro development in sequential and single-step culture medium using time-lapse imaging.

Detailed description

Objective: To study whether a culture medium that allows undisturbed culture supports human embryo development to the blastocyst stage equivalently to a well-established sequential media. Design: Randomized, double-blinded sibling trial. Setting: Independent in vitro fertilization (IVF) clinics. Patient(s): One hundred twenty-eight patients, with 1,356 zygotes randomized into two study arms. Intervention(s): Embryos from each patient were randomly allocated into two study arms to compare embryo development on a time-lapse system using a single-step medium or sequential media.

Interventions

DEVICESingle-step medium

This medium will allow in vitro culture of human embryos for 5/6 days

DEVICEStandard culture medium

This culture system needs media change on day 3 of culture.

Sponsors

Vitrolife
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
BASIC_SCIENCE
Masking
TRIPLE (Subject, Caregiver, Investigator)

Masking description

To minimize the possible bias for the primary outcome, the embryologist performing the morphologic evaluation on day 3 and 5-6 was blinded to the treatments. The physician, the embryologist, and the couple were also blinded to the culture group from which the embryo had been selected for transfer.

Intervention model description

This study was a two-arm, prospective, randomized, controlled clinical trial performed at four independent IVF clinics. Ovarian stimulation and oocyte collection and fertilization were performed as per each clinic's practice. If \>6 oocytes from the patient were fertilized, the resulting zygotes underwent stratified randomization into the two different media. Allocation was performed in a 1:1 ratio according to a computer-generated randomization list for each couple, which was provided in sealed and numbered envelopes to each clinic. Zygotes randomized into G-1/G-2 underwent a media change from G-1 to G-2 on day 3 and subsequent culture until days 5-6. The zygotes randomized to G-TL were cultured continuously without any media change until days 5-6.

Eligibility

Sex/Gender
FEMALE
Age
21 Years to 40 Years
Healthy volunteers
Yes

Inclusion criteria

* 6 or more normal embryos following egg retrieval and fertilization. * Female patients aged 21-40 years or 21-55 years who are using an egg donor. * Patients using fresh or frozen ejaculated sperm

Exclusion criteria

* Previous history of cancer * Day 3 embryo transfer

Design outcomes

Primary

MeasureTime frameDescription
Percentage of good quality blastocysts5 days of in vitro embryo cultureA cohort of human embryos will be divided into two different media. The ability of the media to support human embryo development will be determined using the standard assessment of the percentage of embryos that achieve a defined embryo grade.

Secondary

MeasureTime frameDescription
% GQE DAY 3Measured 3 days after oocyte pick-upPercentage of good quality embryos on day 3 of development
Blast. Utilization rateMeasured 5 and 6 days after oocyte pick-upNumber of blastocyst that are cryopreserved or transfered on either day 5 or 6 of embryo development.
Blast. rateMeasured 5 and 6 days after oocyte pick-up.Number of embryos reaching the blastocyts stage on either day 5 or day 6.

Countries

Sweden, United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 4, 2026